Intravenous AMP 579, a novel adenosine A1/A2a receptor agonist, induces a delayed protection against myocardial infarction in minipig

European Journal of Pharmacology

Volumn 387, Issue 1, 2000, Pages 101-105

  Meng, Heping ^a   McVey, Mathew ^a   Perrone, Mark ^a   Clark, Kenneth L ^a  

^a SANOFI   (France)

Author keywords

Adenosine receptor agonist; Minipig; Myocardial infarction; Protection, delayed

Indexed keywords

4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; ADENOSINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ANIMALS; BLOOD PRESSURE; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROTECTIVE AGENTS; PYRIDINES; RECEPTORS, PURINERGIC P1; SWINE; SWINE, MINIATURE; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0033962863     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00804-3     Document Type: Article

References (21)

1. 1 receptor activation in the rabbit. J. Cardiovasc. Pharmacol. 29:1997;631-638.
2. Baxter G.F., Marber M.S., Patel V.C., Yellon D.M. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation. 90:1994;2993-3000.
3. 1 receptor activation maintains rabbit myocardium in a preconditioned state. J. Am. Coll. Cardiol. 31:1998;1142-1149.
4. 1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits. Cardiovasc. Res. 27:1993;2140-2145.
5. Hamburger S.A., Kopaciewicz L.J., Valocik R.E. A new model of myocardial infarction in Yucatan minipigs. J. Pharmacol. Methods. 25:1991;291-301.
6. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., Kamada T., Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ. Res. 72:1993;1293-1299.
7. 1 receptor mechanism. Am. J. Physiol. 263:1992;H1460-H1465.
8. Leesar, M.A., Stoddard, M., Ahmed, M., Broadbent, J., Bolli, R., 1997. Preconditioning of human myocardium with adenosine during coronary angioplasty. 95, pp. 2500-2507.
9. 1 receptor and KATP channel. Am. J. Physiol. 271:1996;H1769-H1777.
10. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
11. 1 receptor agonist, in myocardial ischaemia-reperfusion injury in the pig. J. Cardiovasc. Pharmacol. 33:1999;285-291.
12. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
13. 2 receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. J. Cardiovasc. Pharmacol. 33:1999;703-710.
14. 2 receptor agonist and cardioprotective. Drug Dev. Res. 45:1998;30-43.
15. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
16. Olafsson B., Forman M.B., Puett D.W., Pou A., Cates C.U., Friesinger G.C., Virmani R. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation. 76:1987;1135-1145.
17. 2 receptor agonist, AMP 579 in a porcine model of myocardial infarction. J. Pharmacol. Exp. Ther. 286:1998;611-618.
18. 1-selective adenosine analogues protects the heart against infarction. Circulation. 85:1992;659-665.
19. Thornton J.D., Thornton C.S., Downey J.M. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am. J. Physiol. 265:1993;H504-H508.
20. Yao Z., Gross G.J. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of K-ATP channels. Circulation. 89:1994;1229-1236.
21. Yellon D.M., Baxter G.F. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J. Mol. Cell. Cardiol. 27:1995;1023-1034.